Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

102 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Assessment of Platelet REACtivity After Transcatheter Aortic Valve Replacement: The REAC-TAVI Trial.
Jimenez Diaz VA, Tello-Montoliu A, Moreno R, Cruz Gonzalez I, Baz Alonso JA, Romaguera R, Molina Navarro E, Juan Salvadores P, Paredes Galan E, De Miguel Castro A, Bastos Fernandez G, Ortiz Saez A, Fernandez Barbeira S, Raposeiras Roubin S, Ocampo Miguez J, Serra Peñaranda A, Valdes Chavarri M, Cequier Fillat A, Calvo Iglesias F, Iñiguez Romo A. Jimenez Diaz VA, et al. JACC Cardiovasc Interv. 2019 Jan 14;12(1):22-32. doi: 10.1016/j.jcin.2018.10.005. JACC Cardiovasc Interv. 2019. PMID: 30621974 Free article. Clinical Trial.
Impact of pentoxifylline on platelet function profiles in patients with type 2 diabetes mellitus and coronary artery disease on dual antiplatelet therapy with aspirin and clopidogrel.
Ueno M, Ferreiro JL, Tomasello SD, Tello-Montoliu A, Capodanno D, Seecheran N, Kodali M, Dharmashankar K, Desai B, Charlton RK, Bass TA, Angiolillo DJ. Ueno M, et al. JACC Cardiovasc Interv. 2011 Aug;4(8):905-12. doi: 10.1016/j.jcin.2011.05.016. JACC Cardiovasc Interv. 2011. PMID: 21851906 Free article. Clinical Trial.
Pharmacodynamic effects of adjunctive cilostazol therapy in patients with coronary artery disease on dual antiplatelet therapy: impact of high on-treatment platelet reactivity and diabetes mellitus status.
Capranzano P, Ferreiro JL, Ueno M, Capodanno D, Dharmashankar K, Darlington A, Desai B, Tello-Montoliu A, Rollini F, Angiolillo DJ. Capranzano P, et al. Catheter Cardiovasc Interv. 2013 Jan 1;81(1):42-9. doi: 10.1002/ccd.24416. Epub 2012 Apr 17. Catheter Cardiovasc Interv. 2013. PMID: 22431415 Clinical Trial.
Cigarette smoking is associated with a dose-response effect in clopidogrel-treated patients with diabetes mellitus and coronary artery disease: results of a pharmacodynamic study.
Ueno M, Ferreiro JL, Desai B, Tomasello SD, Tello-Montoliu A, Capodanno D, Capranzano P, Kodali M, Dharmashankar K, Charlton RK, Bass TA, Angiolillo DJ. Ueno M, et al. JACC Cardiovasc Interv. 2012 Mar;5(3):293-300. doi: 10.1016/j.jcin.2011.09.027. JACC Cardiovasc Interv. 2012. PMID: 22440495 Free article.
Pharmacodynamic effects of cangrelor on platelet P2Y12 receptor-mediated signaling in prasugrel-treated patients.
Rollini F, Franchi F, Tello-Montoliu A, Patel R, Darlington A, Ferreiro JL, Cho JR, Muñiz-Lozano A, Desai B, Zenni MM, Guzman LA, Bass TA, Angiolillo DJ. Rollini F, et al. JACC Cardiovasc Interv. 2014 Apr;7(4):426-34. doi: 10.1016/j.jcin.2013.11.019. Epub 2014 Mar 13. JACC Cardiovasc Interv. 2014. PMID: 24630878 Free article. Clinical Trial.
Low body weight and clinical outcomes in acute coronary syndrome patients: results of the ACHILLES Registry.
Rivera-Caravaca JM, Ruiz-Nodar JM, Tello-Montoliu A, Esteve-Pastor MA, Veliz-Martínez A, Orenes-Piñero E, Valdés M, Pernias-Escrig V, Sandin-Rollán M, Vicente-Ibarra N, Macías-Villanego MJ, Candela-Sánchez E, Lozano T, Carrillo-Alemán L, Marín F. Rivera-Caravaca JM, et al. Eur J Cardiovasc Nurs. 2017 Dec;16(8):696-703. doi: 10.1177/1474515117710155. Epub 2017 May 16. Eur J Cardiovasc Nurs. 2017. PMID: 28509568
Temporal Trends in the Use of Antiplatelet Therapy in Patients With Acute Coronary Syndromes.
Esteve-Pastor MA, Ruíz-Nodar JM, Orenes-Piñero E, Rivera-Caravaca JM, Quintana-Giner M, Véliz-Martínez A, Tello-Montoliu A, PerniasEscrig V, Sandín Rollán M, Vicente-Ibarra N, MacíasVillanego MJ, Candela Sánchez E, Carrillo Alemán L, Lozano T, Valdés M, Marín F. Esteve-Pastor MA, et al. J Cardiovasc Pharmacol Ther. 2018 Jan;23(1):57-65. doi: 10.1177/1074248417724869. Epub 2017 Aug 9. J Cardiovasc Pharmacol Ther. 2018. PMID: 28789568
Bleeding Risk Prediction in Patients With Dual Antiplatelet Therapy Undergoing Coronary Artery Bypass Grafting Surgery Using a Rapid Point-of-Care Platelet Function Test.
Tello-Montoliu A, Albaladejo P, Hernández-Romero D, Taboada R, Albacete CL, Arribas JM, Jara R, Veliz A, López-García C, Cánovas S, Valdés M, Rivera-Caravaca JM, Marín F. Tello-Montoliu A, et al. Circ Cardiovasc Interv. 2018 Dec;11(12):e007264. doi: 10.1161/CIRCINTERVENTIONS.118.007264. Circ Cardiovasc Interv. 2018. PMID: 30525983 No abstract available.
102 results